Yu Chen

Yu Chen

Auto-generated profile, based on publicly available information

Yu Chen

Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Process Biochemistry
Verified
Journal Article
Closed access
JXJing Xia
Jing Xia
QWQi Wang
Qi Wang
QLQuan Luo
Quan Luo
YCYu Chen
Yu Chen
XLXiang-Ru Liao
Xiang-Ru Liao
ZGZheng-Bing Guan
Zheng-Bing Guan

10 August 2021 in Aging
Verified
Journal Article
Open access
JXJifeng Xu
Jifeng Xu
YCYu Chen
Yu Chen
DYDongsheng Yu
Dongsheng Yu
LZLi Zhang
Li Zhang
XDXiaofan Dou
Xiaofan Dou
SZShuijun Zhang
Shuijun Zhang
Osteoporosis is a common aging-related disease diagnosed primarily using bone mineral density (BMD). Extracellular vesicles (EVs) remain unexplored in the context of osteoporosis. Towards this, EVs were isolated from plasma of a discovery cohort with 8 non-osteoporotic and 8 osteoporotic individuals, and nanoparticle tracking analysis (NTA) revealed a significantly higher EV concentration in osteoporotic individuals (P = 0.003). Moreover, EVs concentration showed a linear correlation with bone mineral density (BMD) values (linear correlation coefficient r = 0.9542, deviation from zero, p < 0.001). Results using a mouse model of osteoporosis confirmed that the number of EVs in mice from hindlimb unloading group was significantly higher than that from the age-matched control group (p = 0.015). TaqMan Real-Time PCR demonstrated that miR-335-5p, -320a, -483-5p, and miR-21-5p, were significantly higher expressed in osteoporotic patients compared with non-osteoporotic individuals. Quantitative real-time PCR shown that Wnt1, Wnt5a, Wnt7a, and Wnt9a mRNAs were lower expressed in osteoporosis derived EVs. In vitro functional assay indicated that osteoporosis derived EVs resulted in reduced mineralization in SaOS-2 cells. In conclusion, these results suggest that osteoporosis increased the secretion of EVs which carry higher expression of miRNAs and decreased expression of Wnt signals, further decreased the mineralization capacity in human osteoblasts.

2 June 2025 in Cancer Immunology Research
Verified
Journal Article
Closed access
HZHuakan Zhao
Huakan Zhao
RRRan Ren
Ran Ren
XZXi Zhang
Xi Zhang
MZMengtao Zhan
Mengtao Zhan
JCJinwei Cui
Jinwei Cui
YLYongsheng Li
Yongsheng Li
Analysis of posttranslational modifications (PTM) of proteins can provide new insights, beyond those obtained from analysis of protein levels, for understanding the tumor microenvironment (TME). The characteristics of PTMs in immune cells, along with their spatial distribution, have not been comprehensively integrated, which impedes our understanding of the complexity and heterogeneity of the TME in hepatocellular carcinoma (HCC). In this study, we used a strategy that combines antibodies for specific PTMs with mass cytometry and mass spectrometry technologies to identify PTMs at single-cell resolution. We found that the phosphorylation status of M2 macrophages was substantially altered in tumor tissues from patients with hepatitis B virus (HBV)–positive HCC. Utilizing the expression profiles of site-specific phospho–heat shock protein 27, signal transducer and activator of transcription 1, and tripartite motif–containing protein 28, we classified M2 macrophages into four distinct subtypes: M2-P0 (absence of any of the three phospho-proteins), M2-P1 (presence of one of the three phospho-proteins), M2-P2 (presence of two of the three phospho-proteins), and M2-P3 (presence of all three phospho-proteins). The spatial relationships and functional characteristics of these M2 macrophage subpopulations were assessed using single-cell PTM omics. The abundance of the M2-P2 and M2-P3 subtypes was closely associated with an immunosuppressive TME and responsiveness to immunotherapy in HBV+ HCC. Overall, this study introduces a single-cell PTM-omics approach that uncovers subtypes of macrophages associated with immunotherapeutic responses in HBV+ HCC and provides valuable insights into the immunosuppressive TME of HCC.

1 August 2025
Verified
Other
Open access
HZHuakan Zhao
Huakan Zhao
RRRan Ren
Ran Ren
XZXi Zhang
Xi Zhang
MZMengtao Zhan
Mengtao Zhan
JCJinwei Cui
Jinwei Cui
YLYongsheng Li
Yongsheng Li
Proteomics data of adjacent non-tumor tissues (AT) and Core Tumor (CT) tissues of HBV+ HCC_uniprot_LFQ_quantification